These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9895143)

  • 1. A transcultural study of psychopharmacotherapy for schizophrenia of neuroleptic treatment between Tokyo and Bali.
    Kurihara T; Yagi G; Reverger R; Kawai N; Inada T
    Psychiatry Clin Neurosci; 1998 Dec; 52 Suppl():S188-9. PubMed ID: 9895143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of schizophrenia in a non-industrialized society: comparative study between Bali and Tokyo.
    Kurihara T; Kato M; Reverger R; Yagi G
    Acta Psychiatr Scand; 2000 Feb; 101(2):148-52. PubMed ID: 10706016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low prevalence of high levels of expressed emotion in Bali.
    Kurihara T; Kato M; Tsukahara T; Takano Y; Reverger R
    Psychiatry Res; 2000 Jul; 94(3):229-38. PubMed ID: 10889287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculogyric spasm in Asian psychiatric in-patients on maintenance medication.
    Tan CH; Chiang PC; Ng LL; Chee KT
    Br J Psychiatry; 1994 Sep; 165(3):381-3. PubMed ID: 7994510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public attitudes towards the mentally ill: a cross-cultural study between Bali and Tokyo.
    Kurihara T; Kato M; Sakamoto S; Reverger R; Kitamura T
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):547-52. PubMed ID: 11043804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan.
    Binder RL; Kazamatsuri H; Nishimura T; McNiel DE
    Am J Psychiatry; 1987 Nov; 144(11):1494-6. PubMed ID: 2890308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences in the neuroleptic treatment of schizophrenia.
    Ruiz P; Varner RV; Small DR; Johnson BA
    Psychiatr Q; 1999; 70(2):163-72. PubMed ID: 10392410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of schizophrenia: implications derived from an intercultural hospital comparison between Germany and Japan.
    Hübner-Liebermann B; Spiessl H; Iwai K; Cording C
    Int J Soc Psychiatry; 2005 Mar; 51(1):83-96. PubMed ID: 15864978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
    Leblanc G; Cormier H; Gagné MA; Vaillancourt S
    Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
    Chiu H; Lee S; Leung CM; Wing YK
    Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital.
    Ko GN; Zhang LD; Yan WW; Zhang MD; Buchner D; Xia ZY; Wyatt RJ; Jeste DV
    Am J Psychiatry; 1989 Mar; 146(3):387-9. PubMed ID: 2563929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years.
    Linden M; Godemann F; Gaebel W; Köpke W; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
    Schizophr Bull; 2001; 27(4):585-96. PubMed ID: 11824485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.